Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition
2011

Resveratrol Inhibits Pancreatic Cancer Stem Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Shankar Sharmila, Nall Dara, Tang Su-Ni, Meeker Daniel, Passarini Jenna, Sharma Jay, Srivastava Rakesh K.

Primary Institution: The University of Kansas Medical Center

Hypothesis

Can resveratrol inhibit the stem cell characteristics of pancreatic cancer cells?

Conclusion

Resveratrol effectively inhibits pancreatic cancer stem cell characteristics and can be used for the management of pancreatic cancer.

Supporting Evidence

  • Resveratrol inhibits the growth and development of pancreatic cancer in KrasG12D mice.
  • Resveratrol induces apoptosis in pancreatic cancer stem cells by activating caspase-3/7.
  • Resveratrol inhibits the expression of pluripotency maintaining factors like Nanog and Oct-4.
  • Resveratrol reduces markers of epithelial-mesenchymal transition in pancreatic cancer stem cells.
  • Resveratrol treatment resulted in no detectable pancreatic cancer stem cells in treated mice.

Takeaway

Resveratrol is a natural compound that helps stop the growth of bad cells in pancreatic cancer, making it a potential treatment.

Methodology

The study involved isolating pancreatic cancer stem cells and treating them with resveratrol to assess its effects on cell viability, self-renewal, and expression of stem cell markers.

Limitations

The study primarily focuses on in vitro and animal models, which may not fully replicate human responses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016530

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication